10x Genomics, Inc. Current Federal Tax Expense (Benefit)
10x Genomics, Inc. (TXG) reported Current Federal Tax Expense (Benefit) of -$7.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-02-13
- 10x Genomics, Inc. current federal tax expense (benefit) for fiscal 2025 was -$7.00K, a 101.77% decline from fiscal 2024.
- 10x Genomics, Inc. current federal tax expense (benefit) for fiscal 2024 was $396.00K, a 12.82% increase from fiscal 2023.
- 10x Genomics, Inc. current federal tax expense (benefit) for fiscal 2023 was $351.00K.
- 10x Genomics, Inc. current federal tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$7.00K 10-K · filed 2026-02-13 |
| 2024-12-31 | $396.00K 10-K · filed 2026-02-13 |
| 2023-12-31 | $351.00K 10-K · filed 2026-02-13 |
| 2022-12-31 | $0.00 10-K · filed 2025-02-13 |
| 2021-12-31 | $0.00 10-K · filed 2024-02-15 |
| 2020-12-31 | $0.00 10-K · filed 2023-02-16 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-18 |